Plasma delipidation process induces rapid regression of atherosclerosis and mobilisation of adipose tissue

Journal of Clinical Apheresis

Volumn 20, Issue 3, 2005, Pages 143-153

  Cham, B E ^a,d   Kostner, K M ^a   Shafey, T M ^b   Smith, J L ^a   Colquhoun, D M ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c WESLEY HOSPITAL   (Australia)

^d University of Queensland ^*  (Australia)

Author keywords

Butanol; Cholesterol; Diisopropyl ether; Hyperlipidemic; Reverse cholesterol transport; Roosters

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BUTANOL; BUTANOL DIISOPROPYL ETHER; CHOLESTEROL; LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOCHEMISTRY; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORONARY ARTERY; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; PLASMA DELIPIDATION; PLASMAPHERESIS;

ADIPOSE TISSUE; ANIMALS; ATHEROSCLEROSIS; CHICKENS; CHOLESTEROL; MALE; PLASMA EXCHANGE;

EID: 30544436457     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20060     Document Type: Article

References (48)

1. Spady DK. Reverse cholesterol transport and atherosclerosis regression. Circulation 1999;100:576-578.
2. Wang N, Silver DL, Costet P, Tall AR. Specific binding of Apo A-1 enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000;275:33053-33058.
3. Oram JF, Vaughan AM. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr Opin Lipidol 2000;11:253-260.
4. Trigatti BL, Rigotti A, Braun A. Cellular and physiological roles of SR-B1, a lipoprotein receptor which mediates selective lipid uptake. Biochem Biophys Acta 2000;1529:276-286.
5. Spady DK, Woollett LA, Meidell RS, Hobbs HH. Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in apo A-1 in the mouse. J Lipid Res 1998;39:1483-1492.
6. Forte TM, Goth-Goldstein R, Nordhausen RW, McCall MR. Apolipoprotein A-1 cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res 1993;34:317-324.
7. Clay MA, Newnham HH, Forte TM, Barter PJ. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-1 from HDL and subsequent formation of discoidal HDL. Biochem Biophys Acta 1992;1124:52-58.
8. Tangirala RK, Tsukamoto K, Chun SH, Usher D, Pure E, Rader DJ. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-1 in mice. Circulation 1999;100:1816-1822.
9. Shah PK, Yano J, Reyes O, Chyu KY, Kaul S, Bisgaier CI, Drake S, Cerek B. High-dose recombinant apolipoprotein A-1 Milano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice. Circulation 2001;103:3047-3050.
10. Trachtenberg JD, Cochranen H, Sun S, Sauther M, Lassere M, Choi L, Li AP, Callow AD. Apolipoprotein A-1 inhibits atherosclerotic lesions progression. Circulation 1993;88:541-552
11. Mezdour H, Yamamura T, Nomura S, Yamanoto A. Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1995;113:237-246.
12. Miyazaki A, Sakuma S, Morikawa W, Takine T, Miake F, Terano T, Sakai M, Hakanata H, Sakamoto Y, Naito M, Ruan Y, Takahashi K, Ohta T, Horiuchi S. Intravenous injection of rabbit apolipoprotein A-1 inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1995;15:1882-1888.
13. Ameli S, Hultgarth-Nilsson H, Cercek B, Shah PK, Forrester JS, Ageland H, Nilsson J. Recombinant apolipoprotein A-1 Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation 1994;90: 1935-1941.
14. Soma MR, Donetti E, Parolini C, Sirtori CR, Fumagalli R, Franceschini G. Recombinant apolipoprotein A-1 Milano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits. Circ Res 1995;76:405-411.
15. Carlson IA. Effect of a single infusion of recombinant human proapolipoprotein A-1 liposomes (synthetic HDL) on plasma lipoproteins in patients with low high density lipoprotein cholesterol. Nat Metab Cardiovasc Dis 1995;5:85-91.
16. Lacko AG, Miller NE. International symposium on the role of HDL in disease prevention: report on a meeting. J Lipid Res 1997;38:1267-1273.
17. Nanjee MN, Doran JE, Lerch PG, Miller NE. Acute effects of intravenous infusion of apo A-1/phosphatidyl discs on plasma lipoproteins in humans. Arterioscler Thromb Vasc Biol 1999;19:979-989.
18. Ericksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-1 potential reverse cholesterol transport in humans. Circulation 1999;100:594-598.
19. Sirtori CR, Calabresi L, Franceschini G. Recombinant apolipoproteins for the treatment of vascular diseases. Atherosclerosis 1999;142:29-40.
20. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Muhammad Y, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. Effect of recombinant Apo A-1 Milano on coronary atherosclerosis in patients with acute coronary syndromes. JAMA 2003; 290:2292-2300.
21. Cham BE, Knowles BR. A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res 1976;17:176-181.
22. Curry MD, Alaupovic P, Suenram CA. Determination of apolipoprotein A and its constitutive A-1 and A-11 polypeptides by separate electroimmunossays. Clin Chem 1976; 22:315-322.
23. Avogaro P, Cazzolato G, Bittolo Bon G, Quinci GB, Chinello M. HDL-cholesterol, apolipoproteins A1 and B. Atherosclerosis 1978;31:85-91.
24. Kostner GN, Avogaro P, Bittolo Bon G, Quinci GB, Chinello M. Determination of high density lipoproteins; screening methods compared. Clin Chem 1979;25:939-942.
25. Koren E, Puchois P, McConathy WJ, Fesmire JD, Alaupovic P. Quantitative determination of human plasma apolipoprotein A-1 by a noncompetitive enzyme-linked immunosorbent assay. Clin Chim Acta 1985;147:85-95.
26. Curry MD, McConathy WJ, Fesmire JD, Alaupovic P. Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta 1980;617:503-513.
27. Curry MD, McConathy WJ, Alaupovic P. Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta 1977;491:232-241.
28. Meunier S, Gambert P, Desgres J. Preparative electrophoresis of human apolipoprotein E: an improved method. J Lipid Res 1986;27:1324-1327.
29. Cham BE, Kostner KM, Dwivedy AK, Shafey TM, Fang NX, Mahon MG, Iannuzzi CI, Colquhoun DM, Smith JL. Lipid Apheresis: an in vivo application of plasma delipidation with organic solvents resulting in acute transient reduction of circulating plasma lipids in animals. J Clin Apheresis 1995;10:61-69.
30. Cham BE, Kostner KM, Dwivedy AK, Shafey TM, Fang NX, Mahon MG, Iannuzzi CI, Colquhoun DM, Smith JL. Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns. J Clin Apheresis 1996;11:61-70.
31. Kostner KM, Smith JL, Dwivedy AK, Shafey TM, Fang NX, Mahon MG, Iannuzzi CI, Colquhoun DM, Cham BE. Lecithin cholesterol acyl transferase activity in normocholesterolemic and hypercholesterolemic roosters: modulation by lipid apheresis. Eur J Clin Invest 1997;27:212-218.
32. Innerarity TL, Mahley RW. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry 1978;17:1440-1447.
33. Slater HR, Robertson FW. A comparison of delipidated sera used in studies of sterol synthesis by human mononuclear leukocytes. J Lipid Res 1979;20:413-416.
34. Shakespeare V, Postle AD. Regulation of cholesterol synthesis in skin fibroblasts derived from old people. Atherosclerosis 1979;33:359-364.
35. Slater HR, Smith EB, Robertson FW. The effect of delipidated high density lipoprotein on human leukocyte sterol synthesis. Atherosclerosis 1980;35:41-49.
36. Groener JEM, Van Rozen AE, Erkelens DW. Cholesteryl ester transfer activity. Localization and role in the distribution of cholesteryl ester among lipoproteins in man. Atherosclerosis 1984;50:261-271.
37. Groener JEM, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986;32:283-286.
38. Cham BE, Smith JL. Lipid apheresis in an animal model causes acute reduction in plasma lipid concentrations and mobilization of lipid from liver and aorta. Pharmacol Life Sc. Adv 1994;13:25-32.
39. Cham BE, Knowles BR. In vitro partial relipidation of apolipoprotein in plasma. J Biol Chem 1976;251:6167-6371.
40. Danber DV. Spontaneous artheriosclerosis in chickens. Arch Pathol Lab Med 1942;34:46-51.
41. Danber DV, Katz NL. Experimental cholesterol atheromatosis in an omnivorous animal, the chick. Archiv Pathol Lab Med 1942;34:937-949.
42. Schneider WJ. Lipoprotein receptor in oocyte growth. Clin Invest 1992;70:385-390.
43. Guyard-Dangremont V, Desrumaux C, Gambert P, Lallemont C, Lagrost L. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Comp Biochem Physiol 1998;120:517-525.
44. Schuff-Werner P. Heparin-induzierte extrakorporale LDL-prezipitation (HELP) bei therapie-refraktarer Hypercholesterinamie und koronarer Herzkrenkheit; Einfluß auf die klinische und morphologische regression der koronarsklerose. Z Kardiol 1997;86:57-64.
45. Gertz SD, Kalan JM, Kragel AH. Cardiac morphological findings in patients recombinant tissue plasminogen activator. Am J Cardiol 1990;65:953-961.
46. Barlage S, Frohlich D, Bottcher A, Jauhiainen M, Muller HP, Noetzel F, Rothe G, Schutt C, Linke RP, Lackner KJ, Ehnholm C, Schmitz G. Apo E-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res 2001;42:281-290.
47. Paka L, Kako Y, Obunike JC, Pillarisetti S. Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like lesions. A potential mechanism for the antiatherogenic actions of vascular apolipoprotein E. J Biol Chem 1999;274:4816-4823.
48. Cham BE, Knowles BR. Changes in electrophoretic mobilities of alpha and beta lipoproteins as a result of plasma delipidation. Clin Chem 1976;22:305-309.